Log In

  • Forgotten Password?

Subscribe

Close log in window

    • Whitepapers
    • Promotion Facilities
    • Research Reports
    • Editorial Calendar
Reuters Events Logo
  • More from Reuters Events
    • Whitepapers
    • Editorial Calendar
  • Channels
    • Climate and Energy
    • Natural Capital
    • Social Equality
    • Stakeholder Engagement
    • Reporting and Finance
    • Communications & Engagement
    • Ethics and Governance
  • Events
  • Digital Magazines
    • Sustainable Business Review
    • Ethical Corporation
  • On Demand
  • Editorial Calendar
  • Advertise
    • Newsletter
  • Log In
Reuters Events Logo
Reuters Events Logo

pharmaceuticals

  • Home
  • Climate and Energy
  • Natural Capital
  • Social Equality
  • Reporting and Finance
  • Communications & Engagement
  • Ethics and Governance
  • On demand
Navigation
  • Four steps CEOs can take to increase their social impact – and valuations

    Terry Slavin, (Dec 20, 2017)

    The Boston Consulting Group’s Douglas Beal explains the consultancy’s research showing that companies that put ‘doing good’ at the heart of business strategy outperform their peers

  • #SDG3: Big pharma's blueprint to bring health access to all

    Mark Hillsdon, (Jun 14, 2017)

    With cancer and diabetes now more prevalent in poor countries than in the West, 23 companies, including Pfizer, Novartis, GlaxoSmithKline and Japan's Takeda, are developing partnerships in some of the hardest-hit regions to extend access to life-saving medicines

  • For B2G, you first need B2B

    Claire Manuel, (Feb 27, 2017)

    The Pharmaceutical Supply Chain Initiative, the Global e-Sustainability Initiative and ETI show how competitors can collaborate

  • Sponsored Feature: Innovation and disruption drive sustainability – and vice versa

    EC Newsdesk, (Nov 18, 2016)

    Janssen’s EMEA group chairman Jane Griffiths on the dynamic new business models that are helping society and the bottom line

  • Report Review: CVS Health walks its tobacco-free talk

    Robert Lock, (Nov 18, 2016)

    The US pharma giant’s straight-talking report makes its prescription for a better world easier for investors to swallow

  • Pharmaceuticals Briefing: Accountability – Is transparency the right treatment?

    April Streeter, (Nov 6, 2014)

    The healthcare industry is often seen as being in the pocket of pharmaceutical giants. But some say this closeness is beneficial, and excessive transparency could be damaging

Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.

© Reuters Events 2023 | TERMS OF USE | PRIVACY POLICY | ABOUT US | +44 0207 375 7212 |